← All stocks

GeneDx Holdings Corp.

WGS Net buying
CIK 0001818331 #1896 in the set updated 17 Sep 2026
Bought (120 mo)
$305.78M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$238.66M
$19.30M on a plan · $29.97M straight out of an exercise
Sold at will
$189.40M
183 of 376 sales
Net
+$67.12M
+$116.38M against sales at will

By person

26 insiders · 447 transactions
12.6×

Katherine Stueland holds 12.6 times base salary in stock. $9.03M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $84.22, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meister Keith A.
Director
$128.39M (35)
$3.85M (2)
+$124.54M
4,808,275
16.12%
$404.94M
Casdin Eli
Director
$75.75M (3)
+$75.75M
30,303,586
$2.55B
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% owner
$35.00M (2)
$75.33M (3)
−$40.33M
2,719,692
9.12%
$229.05M
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$100.00K (1)
$38.34M (118) scheduled
−$38.24M
107,227
0.3596%
$9.03M
−52.9%
OPKO HEALTH, INC. entity
10% owner
$5.00M (1)
$29.70M (19)
−$24.70M
2,646,972
8.88%
$222.92M
Casdin Capital, LLC entity
Director
$41.12M (14)
$60.45M (1)
−$19.33M
7,214,328
24.19%
$607.57M
+16.9%
Feeley Kevin
CHIEF FINANCIAL OFFICER
$14.12M (117) scheduled
−$14.12M
41,476
0.1391%
$3.49M
Blackstone Tactical Opportunities Associates III - NQ L.P. entity
10% owner
$10.00M (3)
+$10.00M
162,309
0.5442%
$13.67M
BTO Sema4 Holdings L.P. entity
10% owner
$10.00M (3)
+$10.00M
162,309
0.5442%
$13.67M
Ryan Jason
Director
$161.37K (2)
$8.33M (16)
−$8.17M
118,764
0.3982%
$10.00M
+282.0%
RUCH JOSHUA
Director
$6.09M (15)
−$6.09M
153,382
0.5143%
$12.92M
Dechairo Bryan
Chief Operating Officer
$850.56K (12) scheduled
−$850.56K
0
0.0000%
$0.00
Ro Isaac
Former CFO
$727.24K (8) scheduled
−$727.24K
244,041
0.8183%
$20.55M
Saad Kareem
CHIEF TRANSFORMATION OFFICER
$259.50K (27)
−$259.50K
29,517
0.0990%
$2.49M
Schadt Eric
President & Chief R&D Officer
$192.48K (1)
$412.26K (3) scheduled
−$219.78K
243,380
0.8161%
$20.50M
PFENNIGER RICHARD C JR
Director
$69.91K (3)
+$69.91K
45,082
0.1512%
$3.80M
White Karen Ann
Chief People Officer
$57.27K (17)
−$57.27K
4,761
0.0160%
$400.96K
Assad Shawn
Former CAO
$52.10K (5)
−$52.10K
43,040
0.1443%
$3.62M
+4,303,900%
Coffin James
President and COO
$43.37K (1) scheduled
−$43.37K
22,903
0.0768%
$1.93M
Prentice Anthony
Former Chief Product Officer
$27.44K (5)
−$27.44K
12,102
0.0406%
$1.02M
Clark Daniel Emmett
Former Secretary and GC
$19.88K (5)
−$19.88K
312,207
1.05%
$26.29M
+1,445%
Miao Richard
Former Interim CFO
$7.06K (2)
−$7.06K
24,867
0.0834%
$2.09M
+43.0%
Sherman Rachel E.
Director
58,290
0.1955%
$4.91M
Turner Nat
Director
37,836
0.1269%
$3.19M
Leproust Emily M.
Director
24,852
0.0833%
$2.09M
Pellini Michael J
Director
17,114
0.0574%
$1.44M
Insider
Date
Role
Action
Shares
Price
Amount
RUCH JOSHUA
5 Feb 2025
Director
Exercised, kept
5,816
$7.89
$45.89K
RUCH JOSHUA
17 Jan 2025
Director
Exercised, kept
3,000
$7.89
$23.67K
Showing 250 of 447 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 386
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 24
Sales on a Rule 10b5-1 plan 64
Sales straight out of an exercise 129
Sales at will 183
Transactions with no price 0
Shares from compensation/vesting 150,790,232
Sales filed before the plan box existed 38
History held since 26 Jul 2021